Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of Twyneo (tretinoin and benzoyl peroxide cream) in acne vulgaris
CTR20261443Phase 3Active
- Sponsor
- Sol-Gel Technologies
- Start
- Apr 2026
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of benzoyl peroxide + tretinoin in acne vulgaris, sponsored by Sol-Gel Technologies. Started Apr 2026; status: active.
02
Drugs
benzoyl peroxide + tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20261443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261443.